ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea · Delayed Price · Currency is KRW 92,600
-900 (-0.96%)
Aug 29, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2013 - 2019 |
Raw Pharmaceutical Products | 244.07B | Log In | Log In | Log In | Log In | Upgrade |
Raw Pharmaceutical Products Growth | -2.98% | Log In | Log In | Log In | Log In | Upgrade |
Contract Clinical Trial Research | 29.68B | Log In | Log In | Log In | Log In | Upgrade |
Contract Clinical Trial Research Growth | -11.23% | Log In | Log In | Log In | Log In | Upgrade |
New Drugs and Generic Drug Product | - | Log In | Log In | Log In | Log In | Upgrade |
New Drugs and Generic Drug Product Growth | - | Log In | Log In | Log In | Log In | Upgrade |
New Drugs and Generic Drug Merchandise | - | Log In | Log In | Log In | Log In | Upgrade |
New Drugs and Generic Drug Merchandise Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Service | - | Log In | Log In | Log In | Log In | Upgrade |
Service Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2013 - 2019 |
Switzerland | 95.47B | Log In | Log In | Log In | Log In | Upgrade |
Switzerland Growth | -3.21% | Log In | Log In | Log In | Log In | Upgrade |
United States | 84.74B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | 112.70% | Log In | Log In | Log In | Log In | Upgrade |
Other Countries | 59.41B | Log In | Log In | Log In | Log In | Upgrade |
Other Countries Growth | -10.35% | Log In | Log In | Log In | Log In | Upgrade |
South Korea | 33.88B | Log In | Log In | Log In | Log In | Upgrade |
South Korea Growth | -34.79% | Log In | Log In | Log In | Log In | Upgrade |
Belgium | 250.96M | Log In | Log In | Log In | Log In | Upgrade |
Belgium Growth | -99.11% | Log In | Log In | Log In | Log In | Upgrade |
Spain | - | Log In | Log In | Log In | Log In | Upgrade |